medigraphic.com
ISSN 1561-3070 (Electronic)

2015, Number 2

<< Back Next >>

Rev Cub Oftal 2015; 28 (2)

Contact transscleral cyclophotocoagulation, a valuable option for treatment of the neovascular glaucoma

Gómez MN, Gómez MN, Pérez GH, Moreno DJC, Primelles HR, Torres GO

Language: Spanish
References: 20
Page: 198-204
PDF size: 70.67 Kb.


ABSTRACT

Objective: to describe the results of contact transscleral cyclophotocoagulation as therapeutical alternative in the neovascular glaucoma.
Methods: prospective, longitudinal and descriptive study of one hundred patients with neovascular glaucoma, who had been seen at the provincial glaucoma service of Pinar del Rio province and met the criteria for transscleral cyclophotocoagulation using laser.
Results: sixty nine percent of treated patients were 61-80 years old. Males predominated. Visual acuity remained stable after treatment and the intraocular pressure lowered in 91 % of cases. Sixty two percent reported figures lower than 231 mmHg three months after surgery, 89 % of patients relieved their pain and the regression of neovessels occurred in 75 % of cases.
Conclusions: contact transscleral cyclophotocoagulation achieves the reduction of the intraocular pressure with pain relief and regression of neovessels in patients with neovascular glaucoma; the visual acuity does not change.


REFERENCES

  1. Gómez Martínez N. Glaucoma neovascular: presentación de caso. Rev Cien Méd. 2011 [citado 18 de julio de 2014];15(4):[aprox. 7 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S156131942011000400020&ln g=es&nrm=iso&tlng=es

  2. Chávez Pardo I, González Fernández MC, Aguilar Rodríguez M, Cardoso Guillen E. Intravítrea de triamcinolona en pacientes con rubeosis del iris: presentación de un caso. AMC. 2012 [citado 18 de julio de 2014];16(6):[aprox. 7 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025- 02552012000600010&lng=es&nrm=iso&tlng=es

  3. Cioffi GA. Glaucoma. Madrid: Elsevier S.A; 2012.

  4. García Sánchez J, Martínez de la Casa JM, Méndez Hernández CD, Sáenz Francés F, Santos Bueso E, García Feijóo J. Glaucoma: 100 preguntas más frecuentes. Madrid: Editores Médicos S.A; 2010.

  5. García Feijóo J, Pablo Júlvez LE. Manual de Oftalmología. Madrid: Elsevier S.L; 2012.

  6. Kasuga T, Huang G, Lins S. Laser Therapies: Cyclodestructive Procedures. En: Surgical Innovations in Glaucoma. New York: Springer; 2014. p. 97-102.

  7. Fernández Argones L, Piloto Díaz I, Domínguez Randulfe M. Glaucoma. Temas quirúrgicos. La Habana: Editorial Ciencias Médicas; 2013.

  8. Landín Sorí M, Romero Sánchez RE. Estrategia de intervención sanitaria en pacientes con glaucoma neovascular. Rev Hum Med. 2012 [citado 13 de noviembre de 2014];12(1):[aprox 6 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727- 81202012000100001&lng=es&nrm=iso&tlng=es

  9. Landín Sorí CM, Romero Sánchez RE. Árboles de decisiones para el diagnóstico y tratamiento de pacientes con glaucoma neovascular. AMC. 2012 [citado 13 de noviembre de 2014];16(4):[aprox 11 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025- 02552012000400016&lng=es&nrm=iso&tlng=es

  10. González Rodríguez NT. Presentación de caso atípico de glaucoma neovascular. Rev Arch Méd Camagüey. 2014. [citado 13 de noviembre de 2014];18(1):[aprox 9 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025- 02552014000100013&nrm=iso

  11. Engelbert M, Del Priore LV, Al-Aswad Lama. Neovascular Glaucoma. Contemp Ophthalmol. 2008;7(5):1-6.

  12. Chuang LH, Wang NK, Chen YP, Yeung L, Hwang YS, Chen KJ, et al. Vitrectomy and panretinal photocoagulation reduces the occurrence of neovascular glaucoma in central retinal vein occlusion with vitreous hemorrhage. Retina. 2013;33(4):798-802.

  13. Luke J, Nassar K, Luke M, Grisanti S. Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma: results from a prospective interventional case series. Graefes Arch Clin Exp Ophthalmol. 2013;251(10):2403-13.

  14. Zhou MW, Wang W, Chen SD, Huang WB, Zhang XL. Disorder of blood-aqueous barrier following Ahmed glaucoma valve implantation. Chin Med J. 2013;126(6):1119-24.

  15. Zhou MW, Wang W, Huang WB, Chen SD, Li XY, Gao XB, et al. Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma. Chin Med J. 2013;126(8):1412-7.

  16. Zhou M, Chen S, Wang W, Huang W, Cheng B, Ding X, et al. Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab. Invest Ophthalmol Vis Sci. 2013;54(6):3874-9.

  17. Rotchford AP, Jayasawal R, Madhusudhan S, Ho S, King AJ, Vernon SA. Transscleral diode laser cycloablation in patients with good vision. Br J Ophthalmol. 2010;94(9):1180-3.

  18. Dahan E, Ben Simon GJ, Lafuma A. Comparison of trabeculectomy and Ex-PRESS implantation in fellow eyes of the same patient: a prospective, randomised study. Eye. 2012;26(5):703-10.

  19. Craven ER, Katz LJ, Wells JM, Giamporcaro JE, Stent Study Group. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-tomoderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg.2012;38(8):1339-45.

  20. Landín Sorí M, López Pérez GR, Rodríguez Bencomo DJ. Comportamiento Clínico Epidemiológico del glaucoma neovascular en un Servicio de Glaucoma. AMC. 2009 [citado 28 de septiembre de 2014];13(3):[aprox 10 p.] Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025- 02552009000300009&lng=es&nrm=iso&tlng=es




2020     |     www.medigraphic.com